Next Article in Journal
Design and Synthesis of Bis-amide and Hydrazide-containing Derivatives of Malonic Acid as Potential HIV-1 Integrase Inhibitors
Previous Article in Journal
Characterization of Hydrocortisone Biometabolites and 18S rRNA Gene in Chlamydomonas reinhardtii Cultures
Article Menu

Export Article

Open AccessArticle
Molecules 2008, 13(10), 2426-2441;

Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly

School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, P.R. China
The National Center for Drug Screening, Chinese Academy of Sciences, Shanghai 201203, P.R. China
School of Biotechnology, Southwest University, Chongqing 400715, P.R. China
Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P.R. China
Authors to whom correspondence should be addressed.
Received: 30 September 2008 / Revised: 18 September 2008 / Accepted: 18 September 2008 / Published: 1 October 2008
Full-Text   |   PDF [463 KB, uploaded 18 June 2014]   |  


CCR5, as the major co-receptor for HIV-1 entry, is an attractive novel target for the pharmaceutical industry in the HIV-1 therapeutic area. In this study, based on the structures of maraviroc and 1,4-bis(4-(7-chloroquinolin-4-yl)piperazin-1-yl)butane-1,4-dione (1), which was identified using structure-based virtual screening in conjunction with a calcium mobilization assay, a series of novel small molecule CCR5 antagonists have been designed and synthesized through fragment assembly. Preliminary SARs were obtained, which are in good agreement with the molecular binding model and should prove helpful for future antagonist design. The novel scaffold presented here might also be useful in the development of maraviroc-derived second generation CCR5 antagonists. View Full-Text
Keywords: CCR5 antagonist; fragment assembly; HIV-1; molecular modeling CCR5 antagonist; fragment assembly; HIV-1; molecular modeling

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Liu, Y.; Zhou, E.; Yu, K.; Zhu, J.; Zhang, Y.; Xie, X.; Li, J.; Jiang, H. Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly. Molecules 2008, 13, 2426-2441.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top